A Clinical, Pathologic and Prognostic Features of Adnexal Masses Operated on during Pregnancy.
- Author:
Byung Ju JI
1
;
Hyeon Ju LEE
;
Hee Woong JEONG
;
Young Ho LEE
;
Sang Tak EUM
;
Ki Sung CHUNG
Author Information
1. Department of Obstetrics & Gynecology, Masan Samsung Hospital College of Medicine, SungKyunKwan University, Masan, Korea.
- Publication Type:Original Article
- Keywords:
Pregnancy;
Adnexal mass;
Fetal outcome
- MeSH:
Abortion, Spontaneous;
Cystadenoma, Serous;
Female;
Humans;
Infant;
Mucins;
Pregnancy*;
Pregnant Women;
Premature Birth;
Retrospective Studies;
Teratoma
- From:Korean Journal of Obstetrics and Gynecology
2001;44(7):1281-1284
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
OBJECTIVE: The purpose of this study was to evaluate retrospective data concerning patients with adnexal masses that were managed surgically during pregnancy and their effect on fetal outcome. METHODS: Data were reviewed concerning pregnant women who required surgery at our hospital from January 1991 to December 2000 for an adnexal mass. RESULTS: In the recent 10 years at our hospital a total of 47 pregnant women aged 27.9+/-3.6 years were diagnosed with adnexal masses that required surgery. The masses were removed at 12.3+/-3.7 weeks of gestation and maximum diameter was 8.4+/-2.3 cm. The pathologic features of the 47 lesions were as follows : 17 mature cystic teratomas, 14 epithelial origins (12 serous cystadenoma, 2 mucinous cystadenoma), 9 functional cysts, 4 endometriotic cysts, 2 paraovarian cysts, 1 malignant neoplasm. Of the 41 patients for whom the outcome of pregnancy was available, 2 (4.2%) gave preterm birth before 37 weeks, while 4 (8.5%) experienced spontaneous abortion. There were not any perinatal death for the 43 infants. CONCLUSION: Although our studies are smaller for confirmation, so larger studies are required, but our results suggest that an adnexal mass may be associated with an adverse fetal outcome. Surgical intervention at<22 weeks of gestation might not have been related to the adverse fetal outcomes.
